Shares of major U.S. drugmakers fell on Friday after President-elect Donald Trump picked anti-vaccine activist Robert F.
Speaker of the House Mike Johnson says releasing the ethics committee report on the Florida lawmaker would set "a terrible precedent".
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback